Taylor & Francis

Prepare your manuscript for Clinical Toxicology.

Review the checklist, choose your article type, and turn your draft into a cleaner submission package.

Checked 2026-08-01

Article types

Review
Letter
Clinical Trial
Case Report
Systematic Review
Lectio
Letter to the Editor
Research Article
Protocol
Editorial

Readiness requirements

Review the key details below, or download the complete checklist with every stored source-backed requirement.

Abstract length

  • Provide an author-written abstract of no more than 300 words.
  • Use a structured abstract.
Show 10 more
  • The article should typically be no more than 4,000 words, not including a structured abstract of 500 words, and should include an Introduction.
  • Provide a comprehensive overview of an important area of toxicology, with due emphasis being given to developments during the past five years (5,000-10,000 words, not including a structured abstract of 600 words and up to 150 references).
  • Mini-reviews should summarize the evidence base (maximum 3,000 words, not including a structured abstract of up to 400 words and up to 50 references) that answers a specific question or controversy in clinical toxicology.
  • The abstract must have the headings Introduction, Methods, Results, Discussion and Conclusion when applicable.
  • Trial registration numbers should be included in the abstract, with full details in the methods section.
  • Your abstract should focus on what your research is about, what methods have been used, and what you found out.
  • Review: Should the Editor ask you to revise your manuscript during the peer review process, please ensure that your abstract is updated to reflect any changes made to the manuscript.
  • The instructions for authors for each journal will give specific guidelines on what’s required here, including whether it should be a structured abstract or graphical abstract, and any word limits.
  • The abstract should be entered into the relevant box in the submission system and be present in your manuscript files too.
  • Rapid Communications are limited to 2,000 words, not including a structured abstract of up to 200 words.

Keywords

  • Include or confirm the keywords required by the journal. Articlo checks this item and flags anything that still needs author input.

Reference style

  • Articlo formats your supplied references in Vancouver style and checks that citations match the reference list; source validity is not verified.
  • All citations in the manuscript should be in brackets, not superscript, and before the period.
Show 9 more
  • The reference number should be spaced in front of the reference in brackets with no punctuation, like this: [1].
  • The page numbers should always be included and completely written like this 120-125, not 120-5, as the last part of the reference.
  • Readers should be able to interpret the table without reference to the text.
  • If you reply yes, you will be required to provide the DOI, pre-registered DOI, hyperlink, or other persistent identifier associated with the data set(s).
  • Discussion: This should include implications of the findings and their limitations, with reference to all other relevant studies and the possibilities these suggest for future research.
  • A DOI is not required in the references.
  • References are normally limited to 20.
  • The number of authors listed in references is limited to three.
  • Please note that we do not re-publish Congress Abstracts that have already been published in a journal unless substantial additional material is included and the citation for the original material is one of the five references.

Figure and table rules

  • Keep every figure and table numbered, captioned, and cited in the manuscript. Keep figures embedded; Articlo also extracts numbered source files for the package.
  • Group figures at the end of the manuscript.
Show 16 more
  • Group tables at the end of the manuscript.
  • Figures should be high quality (1200 dpi for line art, 600 dpi for grayscale and 300 dpi for colour, at the correct size).
  • Tables and figures Show clearly in your article text where the tables and figures should appear, for example, by writing [Table 1 near here].
  • The focus of the manuscript should be original images (up to 2-3 high-quality figures) of classic, interesting or unusual findings that facilitate the clinical or laboratory diagnosis of toxicological disease.
  • Figures should be supplied in one of our preferred file formats: PS, JPEG, TIFF.
  • Any unnecessary identifying patient information, such as a patient’s name, should be hidden or removed from the figures before submission.
  • Letter: Tables All titles, column headings, labelling should only have the initial capital letter in uppercase, unless a proper noun.
  • Tables should present new information rather than duplicating what is in the text.
  • The statistical P should be capitalized and italicized in the manuscript, tables, and figures.
  • The statistical n should be italicized in the manuscript, tables, and figures.
  • There is a maximum of four tables or figures.
  • Images: These may be images of physical findings, radiographs or microscopy and should have a detailed descriptive legend.
  • Figures should be saved separately from the text.
  • It’s very important that you have been given permission to use any tables or figures you are reproducing from another source before you submit.
  • Letter: Figures All titles, column headings, labelling should only have the initial capital letter in uppercase, unless a proper noun.Your figures should be uploaded separately to your manuscript files, using the file type ‘Figure’.
  • Check the instructions for authors to see how you should supply tables and figures, whether at the end of the text or in separate files, and follow any guidance given on the submission system.

Funding statement

  • You should declare only the acquired funds and grants that are directly relevant to the work reported in your article; for example, This work was supported by the [Funding Agency #1] under Grant [number xxxx]; [Funding Agency #2] under Grant [number xxxx]; and [Funding Agency #3] under Grant [number xxxx].

Competing interests

  • Include or confirm the competing interests required by the journal. Articlo checks this item and flags anything that still needs author input.

Data availability statement

  • Add or confirm the author-written Data availability statement; Articlo flags it if author input is still needed.
  • Authors are required to cite any data sets referenced in the article and provide a Data Availability Statement.

Ethics statement

  • Add or confirm the author-written Ethics statement; Articlo flags it if author input is still needed.
  • Use labels and arrows to identify points of interest on the image and be certain to remove any identifying patient information.
Show 9 more
  • In settings where ethics approval for non-interventional studies (e.g. surveys) is not required, authors must include a statement to explain this.
  • Authors should familiarise themselves with our policy on participant/patient privacy and informed consent.
  • Review: A statement of informed patient consent, or approval (or exemption statement) by an ethics committee/ investigational review board must normally be submitted with the manuscript.
  • Review: All original research papers involving humans, animals, plants, biological material, protected or non-public datasets, collections or sites, must include a written statement in the Methods section, confirming ethical approval has been obtained from the appropriate local ethics committee or Institutional Review Board and that where relevant, informed consent has been obtained.
  • Editorial: Consent All authors are required to follow the ICMJE requirements and Taylor & Francis Editorial Policies on privacy and informed consent from patients and study participants.
  • Authors must include a statement to confirm that any patient, service user, or participant (or that person’s parent or legal guardian) in any type of qualitative or quantitative research, has given informed consent to participate in the research.
  • Case Report: a clinical case report detailing their medical history, identifiable images or media content, etc), authors must include a statement to confirm that they have obtained written informed consent to publish the details from the affected individual (or their parents/guardians if the participant in not an adult or unable to give informed consent; or next of kin if the participant is deceased).
  • Case Report: For submissions where patients or participants can be potentially identified (e.g.
  • Review: Clinical Toxicology requires that studies involving humans, both volunteers and patients, or animals be approved by an ethics committee/ institutional review board, in accordance with approved published guidelines, prior to actually performing the research and publishing the data.

Blinded manuscript

  • Review: Remove author names, affiliations, acknowledgements, and other direct identifiers from the blinded manuscript file.
  • The PDF should be uploaded as the “Manuscript - with author details”/”Manuscript - anonymous” file.
Show 1 more
  • Review: Please note that Clinical Toxicology follows a double-blind peer review policy, which means that you need to upload an anonymized version of your manuscript as one of the files when submitting your paper.

Cover letter

  • Letter: Provide the claims and editor-specific context for the cover letter; Articlo creates an editable companion without inventing content.
  • Letter: Cover Letter Please outline why your manuscript should be published in Clinical Toxicology and why you feel it will be an important publication in this subject area.
Show 6 more
  • Letter: When submitting their manuscript, authors should provide details of the additional material not published previously in a cover letter.
  • Using Third-Party Material in Your Paper You must obtain the necessary permission to reuse third-party material in your article.
  • Letter / Letter to the Editor: Listing more than six authors for an Image article should be justified in the cover letter to the Editor-in-Chief, outlining the contribution of each author to the manuscript.
  • Review: The use of short extracts of text and some other types of material is usually permitted, on a limited basis, for the purposes of criticism and review without securing formal permission.
  • If you wish to include any material in your paper for which you do not hold copyright, and which is not covered by this informal agreement, you will need to obtain written permission from the copyright owner prior to submission.
  • Letter: Manuscripts must meet one of the following criteria which should be specified in the cover letter: i.

Title page and author information

  • Letter: The author affiliations should be labelled with a lowercase letter starting with a,b,c.that is in superscript at the end of the name, e.g. Anna Smith a.
  • Letter: Title Page The manuscript’s title should only have the first letter and any proper nouns within the title capitalised.
Show 2 more
  • Please include all authors’ full names, affiliations, and email addresses on the cover page and ensure that the author names and order exactly match what you enter into our submission system.
  • One author will need to be identified as the corresponding author, with their email address and (optional) postal address displayed in the article.

Article structure and word limits

  • Margins Margins should be at least 2.5cm (1 inch).
  • Numbers less than 10 should be written out.
Show 46 more
  • Letters in response to an article should be submitted within 8 weeks of the initial online publication of the article they are commenting on, and the original authors will be given the opportunity to reply.
  • Review: These instructions will ensure we have everything required so your paper can move through peer review, production and publication smoothly.
  • Your research funder or your institution may require you to publish your article open access.
  • Use our APC finder to view the APC for this journal.
  • The guidelines should be used in constructing scientific studies, followed during their conduct, and used as a checklist and included with the manuscript upon submission.
  • Finally, good scientific writing practices should be followed.
  • Letter: The institution connected with the author should have the same lowercase letter at the beginning of the institution, e.g. a University of.
  • Please use SI units (non-italicized), though mass units should be given in parentheses.
  • Such reports should include a description of the new or unusual features, or observations that generate a hypothesis or support a change in clinical practice.
  • These reports should focus on the observations presented and not include lengthy reviews of the existing medical literature.
  • You must make it clear to the Editor what your case adds to the field of clinical toxicology.
  • These submissions should include adequate and appropriate validation, and any datasets associated with the paper must include all experimental controls, if appropriate.
  • If there are concerns about research subject-identifying factors in datasets, these should be discussed with tthe Editor-in-Chief Kirk Cumpston prior to submission.
  • Case Report: This category should not be used as a substitute for Rapid Communications or to submit a case report.
  • Title: The title should be short and descriptive.
  • When authors are replying to multiple letters, the word "Comment" in the title should be changed to "Comments".
  • These are invited contributions by the journal’s Affiliated Societies which should be discussed with the Editor-in-Chief Kirk Cumpston prior to submission.
  • If there are more, the third name should be followed by et al.
  • For all NIH/Wellcome-funded papers, the grant number(s) must be included in the declaration of interest statement.
  • Clinical Trial: Clinical trials should be registered prospectively – i.e. before participant recruitment.
  • Editorial: Authors of retrospectively registered trials must be prepared to provide further information to the journal editorial office if requested.
  • Clinical Trial: The clinical trial registry should be publicly accessible (at no charge), open to all prospective registrants, and managed by a not-for-profit organization.
  • All research studies on humans (individuals, samples, or data) must have been performed in accordance with the principles stated in the Declaration of Helsinki.
  • Please include all relevant safety precautions; and cite any accepted standard or code of practice.
  • You will also need to upload your LaTeX source files, which should be uploaded as a single zip file alongside your submission and marked as “LaTeX Source Files”.
  • Queries Should you have any queries, please visit our Author Services website or contact us here.
  • Before you submit your article, make sure you’ve checked the instructions for authors for your chosen journal, so you are aware of everything required.
  • Most journals create image descriptions during the production process, but a minority may require authors to provide image descriptions.
  • Review: Running heads and received dates These aren’t required when submitting a manuscript for review.
  • Five to ten key words should be listed.
  • They should be separated by semicolon.
  • Use this website for the correct use of pharmaceutical names: https://www.who.int/teams/health-product-and-policy-standards/inn/inn-lists.
  • Use commas for four-digit numbers.
  • Latin terminology should be italicized.
  • These should either: i.
  • Clinical Trial: Clinical Trials Registry In order to be published in a Taylor & Francis journal, all clinical trials must have been registered in a public repository, ideally at the beginning of the research process (prior to participant recruitment).
  • The process of obtaining consent to publish should include sharing the article with the individual (or whoever is consenting on their behalf), so that they are fully aware of the content of the article before it is published.
  • Please note that data should only be shared if it is ethically correct to do so, where this does not violate the protection of human subjects, or other valid ethical, privacy, or security concerns.
  • Special characters If you are preparing your manuscript in Microsoft Word and your article contains special characters, accents, or diacritics, we recommend you follow these steps: European accents (Greek, Hebrew, or Cyrillic letters, or phonetic symbols): choose Times New Roman font from the dropdown menu in the “Insert symbol” window and insert the character you require.
  • Special characters If you are preparing your manuscript in Microsoft Word and your article contains special characters, accents, or diacritics, we recommend you follow these steps: Asian languages (such as Sanskrit, Korean, Chinese, or Japanese): choose Arial Unicode font from the dropdown menu in the “Insert symbol” window and insert the character you require.
  • If there is a colon in the title with text following it, it should not be capitalised.
  • If you do not, your paper is likely to be returned for the necessary corrections to be made.
  • Review / Case Report: We do not publish manuscripts of the type, "Case Report(s) and Review of the Literature".
  • If you are at the early stage of your research, you may also need to read how to start writing a journal manuscript.
  • It is essential that details of the literature search methodology are provided, i.e. the databases searched (normally MEDLINE and at least one or preferably two other databases), the search terms and inclusive dates, and any selectivity criteria imposed.
  • Image descriptions are typically used by systems such as pronouncing screen readers to make images accessible to people that cannot read or see the object due to a visual disability.

Reporting guidelines

  • Include or confirm the reporting guidelines required by the journal. Articlo checks this item and flags anything that still needs author input.

Statistical reporting

  • You should describe your selection of the observational or experimental participants, identify the methods, apparatus and procedures in sufficient detail to allow others to reproduce the results, and describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results.

Preprints and prior publication

  • If you have shared an earlier version of your Author’s Original Manuscript on a preprint server, please be aware that anonymity cannot be guaranteed.

Artificial intelligence disclosure

  • Please read our guidance on using AI tools in your research and manuscript preparation to understand scenarios where their use may be permissible, and the required information that must be disclosed.

Authorship and originality

  • Preparing Your Paper All authors submitting articles to Clinical Toxicology should should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, prepared by the International Committee of Medical Journal Editors (ICMJE).

Study reporting guidelines

  • The appropriate guidelines should be adhered to when reporting on randomized controlled trials (e.g. CONSORT).
  • If animals have been used, the approval of an animal care and use committee should also be submitted.
Show 3 more
  • For animal studies, approval must have been obtained from the local or institutional animal use and care committee.
  • Reviews should provide a scholarly, evidence-based, critical analysis of topics relevant to practicing clinical toxicologists and other clinicians and scientists at the interface with acute care, occupational and environmental medicine, public health, regulatory toxicology, pharmacology and pharmaceutics, and analytical and forensic pathology.
  • Case Report / Systematic Review: Authors are strongly encouraged to follow the reporting guidelines on the EQUATOR Network, including, but not limited to, the CONSORT guidelines for randomized studies, the STROBE guidelines for observational studies, the CARE guidelines for case reports, the SAMPL guidelines for statistical reporting, and the PRISMA guidelines for systematic reviews.

Language and text style

  • Journal abbreviations should be according to ISO 4.
  • If important to include for context, authors should consider using language such as “…we were unable to locate prior cases…a higher published concentration…” etc.
Show 10 more
  • Letter: should be in bold italics, with an initial capital letter for any proper nouns.
  • Letter: should be in italics, with an initial capital letter for any proper nouns.
  • should be in bold italics, at the beginning of a paragraph.
  • should be in italics, at the beginning of a paragraph.
  • Authors may write either in UK or US English but must be consistent throughout their manuscript.
  • Please use double quotation marks, except where "a quotation is 'within' a quotation".
  • Please note that long quotations should be indented without quotation marks.
  • Limit abbreviations in your manuscript.
  • Letter: Headings This will show you the different levels of the heading section in your article: Second-level headings should be in bold italics, with an initial capital letter for any proper nouns.
  • Letter: Headings This will show you the different levels of the heading section in your article: Third-level headings should be in italics, with an initial capital letter for any proper nouns.

Manuscript structure

  • Letter: (e.g. Introduction, Conclusion) should be in bold, with an initial capital letter for any proper nouns.
  • Introduction: This section should state the relevance and background to the study, its rationale and main objectives.
Show 11 more
  • Protocol: Methods: This section should include only information that was available at the time the plan or protocol for the study was being written.
  • Clinical Trial: Details, including the clinical trial registration number, must be provided in the methods section if the research has been conducted on human volunteers.
  • Conclusions: This must summarize the main paper.
  • The manuscript must have an Introduction, Methods, Results, Discussion and Conclusion when applicable.
  • The Introduction should state the relevance and background to the study, its rationale and main objectives.
  • Conclusion: This should summarize the relevance of the image to toxicological practice.
  • The headings should be in bold.
  • Introduction: This should provide a background to the feature or finding by briefly reviewing published reports of similar findings that have facilitated the diagnosis of the toxicological presentation.
  • Letter: Headings This will show you the different levels of the heading section in your article: First-level headings (e.g. Introduction, Conclusion) should be in bold, with an initial capital letter for any proper nouns.
  • The body of the article should include the following sections: Introduction; Methods; Results; Discussion; Conclusions.
  • Clinical Trial: However, for clinical trials that have not been registered prospectively, Taylor & Francis journals requires retrospective registration to ensure the transparent and complete dissemination of all clinical trial results which ultimately impact human health.

Article type and manuscript length

  • An advisory maximum word limit of 3,000 words is suggested for an initial original submission, not including a structured abstract of up to 300 words.
  • The main text should not exceed 3,000 words, not including a structured abstract of up to 300 words and at most 50 references.
Show 3 more
  • The main text should not exceed 750 words, not including the structured abstract of up to 150 words and, at most, 10 references.
  • Please note that only common abbreviations should be used in the main text, which should be explained at first use.
  • Structure Your paper should be compiled in the following order: title page; abstract; keywords; main text introduction, materials and methods, results, discussion; conclusion; acknowledgements; declaration of interest statement; data availability statement; funding; references; appendices (as appropriate); table(s) with caption(s) (on individual pages); figures; figure captions (as a list).

What your package checks

Abstract: 300 words
Paper: 4,000 words
References: Vancouver
Declarations: Data availability, Ethics
Format: Times New Roman

Source transparency

This preparation guide uses published journal-specific author requirements. Journal instructions can change, so authors should complete a final review before submission.

Open official guideline source